Implementation of Internet-based Psychotherapy for Symptoms of Depression, Insomnia and Anxiety in Primary Care in the Cities of Indaiatuba and Jaguariuna
1 other identifier
interventional
268
1 country
2
Brief Summary
The main objective of this study is to evaluate the effectiveness and success of implementing internet-based cognitive behavioral psychotherapy (iCBT) guided by a therapist for symptoms of depression, insomnia and anxiety in individuals who did not respond to an automated intervention in primary care in the cities of Indaiatuba and Jaguariúna. Method: This is a pragmatic, prospective, randomized, two-arm, parallel-group, controlled clinical trial, comparing a therapist-guided Internet-based cognitive behavioral therapy (iCBT) treatment associated with usual care versus usual care alone (UC) for symptoms of depression, insomnia and anxiety in adults who attend primary care in the cities of Indaiatuba and Jaguariúna and who did not respond to a first phase of treatment with automated iCBT (not guided by a therapist) focused on these groups of symptoms. The results will be accessed during treatment, in the immediate post-treatment (after two weeks of completing treatment) and at 3 and 6 month follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable depression
Started Jan 2026
Typical duration for not_applicable depression
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 5, 2024
CompletedFirst Posted
Study publicly available on registry
February 10, 2025
CompletedStudy Start
First participant enrolled
January 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2028
February 10, 2025
January 1, 2025
1.8 years
August 5, 2024
February 7, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
PHQ-9 - Patient Health Questionnaire-9
Reduction of 50% or more in the PHQ-9 score
3 month follow up
ISI - Insomnia Severity Index
Reduction of 8 points or more in the ISI score
3 month follow up
GAD-7 - Generalized Anxiety Disorder 7-item
Reduction of 50% or more in the GAD-7
3 month follow up
Study Arms (2)
iCBT
EXPERIMENTALFor participants allocated to ICBT, in addition to the usual care performed in the primary unit, these individuals will also receive digital intervention through an online platform specifically developed for this purpose. Depression and anxiety intervention will consist of 10 specific modules for the treatment of each disorder to be performed within 10 weeks. Insomnia intervention will consist of 9 specific modules for the treatment of insomnia, to be performed within 8 weeks. These modules use concepts associated with cognitive behavioral therapy and third-generation behavioral therapy and were created through the transcultural and digital adaptation the therapeutic ingredients present in consumed treatment manuals in the literature. In all modules, a therapist will be designated to accompany each patient.
Treatment as usual
NO INTERVENTIONPatients allocated to this arm will continue to receive the usual treatment in their health units, which usually consists of psychotropic drugs and psychological support
Interventions
Intervention based on cognitive and behavioral techniques, such as psychoeducation on anxiety, depression and insomnia; muscle relaxation and breathing techniques; sleep hygiene techniques, behavioral activation and mindfulness techniques
Eligibility Criteria
You may qualify if:
- Participants included in the first phase of the study;
- Depression complaints with significant scores for depression\> = 10 points; and/or
- Insomnia complaints with significant score for insomnia\> = 11; and/or
- Complaints of significant score for anxiety\> = 10.
- participants with significant symptoms in more than one domain, together with the professional, will be invited to elect a main focus of treatment, or by be the main problem and/or the one the patient is most motivated to treat.
You may not qualify if:
- Individuals who have acute suicide risk, evaluated by positive response (1, 2 or 3) to PHQ-9 item 9 and considered severe (suicidal illusion) in the Suicide Risk Assessment Protocol (S-RAP) will be excluded.
- Individuals identified as bass in S-rap will be sent for emergency care according to security monitoring protocol presented in the topic "Evaluation and Risk Monitoring" of this project.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Basic Health System
Indaiatuba, São Paulo, Brazil
Basic Health System
Jaguariúna, São Paulo, 13.910.027, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Paulo Rossi Menezes, PhD
University of Sao Paulo
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 5, 2024
First Posted
February 10, 2025
Study Start
January 1, 2026
Primary Completion (Estimated)
November 1, 2027
Study Completion (Estimated)
November 1, 2028
Last Updated
February 10, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- After the studies are published.
- Access Criteria
- Upon request from others researchers.
Data and analysis codes will be shared on the OSF platform after the study is published and under request.